| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Food Hypersensitivity | 74 | 2024 | 729 | 15.360 |
Why?
|
| Peanut Hypersensitivity | 51 | 2023 | 219 | 14.520 |
Why?
|
| Allergens | 100 | 2024 | 1432 | 10.520 |
Why?
|
| Hypersensitivity | 45 | 2024 | 1171 | 9.920 |
Why?
|
| Desensitization, Immunologic | 58 | 2024 | 556 | 9.780 |
Why?
|
| Climate Change | 19 | 2024 | 501 | 6.820 |
Why?
|
| Immunoglobulin E | 61 | 2024 | 1502 | 5.330 |
Why?
|
| Asthma | 65 | 2024 | 6234 | 5.010 |
Why?
|
| Air Pollution | 22 | 2024 | 2359 | 4.550 |
Why?
|
| Dermatitis, Atopic | 18 | 2024 | 731 | 3.480 |
Why?
|
| Air Pollutants | 21 | 2024 | 2896 | 3.450 |
Why?
|
| T-Lymphocytes, Regulatory | 28 | 2022 | 3080 | 2.890 |
Why?
|
| Anti-Allergic Agents | 15 | 2018 | 153 | 2.770 |
Why?
|
| Immune Tolerance | 26 | 2024 | 2303 | 2.570 |
Why?
|
| Basophils | 18 | 2024 | 407 | 2.540 |
Why?
|
| Plant Proteins | 13 | 2022 | 370 | 2.480 |
Why?
|
| Environmental Exposure | 28 | 2024 | 4486 | 2.340 |
Why?
|
| Antigens, Plant | 18 | 2023 | 104 | 2.300 |
Why?
|
| Eosinophilic Esophagitis | 10 | 2023 | 197 | 2.270 |
Why?
|
| Particulate Matter | 16 | 2024 | 2605 | 2.250 |
Why?
|
| Epigenesis, Genetic | 16 | 2024 | 3802 | 2.120 |
Why?
|
| Antibodies, Anti-Idiotypic | 10 | 2018 | 357 | 2.120 |
Why?
|
| Nut Hypersensitivity | 8 | 2023 | 33 | 2.120 |
Why?
|
| Cytokines | 42 | 2024 | 7396 | 2.110 |
Why?
|
| Anaphylaxis | 11 | 2023 | 757 | 2.080 |
Why?
|
| Food | 15 | 2024 | 774 | 1.880 |
Why?
|
| Immunotherapy | 20 | 2023 | 4652 | 1.820 |
Why?
|
| Administration, Oral | 32 | 2023 | 4021 | 1.820 |
Why?
|
| Emollients | 4 | 2023 | 42 | 1.670 |
Why?
|
| Th2 Cells | 12 | 2024 | 1060 | 1.650 |
Why?
|
| Humans | 383 | 2024 | 761504 | 1.470 |
Why?
|
| STAT5 Transcription Factor | 5 | 2022 | 265 | 1.440 |
Why?
|
| Forkhead Transcription Factors | 10 | 2021 | 1616 | 1.420 |
Why?
|
| DNA Methylation | 15 | 2024 | 4398 | 1.270 |
Why?
|
| Fossil Fuels | 3 | 2024 | 53 | 1.250 |
Why?
|
| Interleukin-10 | 9 | 2023 | 1175 | 1.250 |
Why?
|
| CD4-Positive T-Lymphocytes | 11 | 2021 | 4369 | 1.190 |
Why?
|
| Hypersensitivity, Immediate | 4 | 2023 | 347 | 1.170 |
Why?
|
| Rhinitis, Allergic, Seasonal | 3 | 2020 | 104 | 1.160 |
Why?
|
| Environmental Pollution | 3 | 2022 | 124 | 1.130 |
Why?
|
| T-Lymphocyte Subsets | 9 | 2020 | 1802 | 1.100 |
Why?
|
| Eosinophils | 6 | 2022 | 950 | 1.100 |
Why?
|
| Egg Hypersensitivity | 2 | 2019 | 47 | 1.100 |
Why?
|
| Ozone | 4 | 2023 | 483 | 1.070 |
Why?
|
| Child | 95 | 2024 | 80153 | 1.050 |
Why?
|
| Biological Products | 5 | 2024 | 914 | 1.030 |
Why?
|
| Global Warming | 5 | 2024 | 79 | 1.030 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 3 | 2021 | 974 | 1.030 |
Why?
|
| Milk Hypersensitivity | 6 | 2021 | 82 | 1.010 |
Why?
|
| Immune System | 4 | 2023 | 796 | 1.010 |
Why?
|
| Allergy and Immunology | 2 | 2019 | 176 | 1.010 |
Why?
|
| Th1 Cells | 6 | 2021 | 1036 | 1.000 |
Why?
|
| Nitrogen Dioxide | 4 | 2024 | 522 | 0.990 |
Why?
|
| CD8-Positive T-Lymphocytes | 11 | 2024 | 4580 | 0.980 |
Why?
|
| Immunity, Innate | 14 | 2024 | 3065 | 0.960 |
Why?
|
| Immunoglobulin G | 19 | 2024 | 4544 | 0.960 |
Why?
|
| Vehicle Emissions | 3 | 2024 | 656 | 0.920 |
Why?
|
| Arsenic | 3 | 2017 | 362 | 0.910 |
Why?
|
| Pollen | 2 | 2021 | 80 | 0.900 |
Why?
|
| Environmental Pollutants | 3 | 2024 | 1277 | 0.890 |
Why?
|
| CpG Islands | 5 | 2021 | 1230 | 0.860 |
Why?
|
| Photosynthesis | 1 | 2023 | 68 | 0.840 |
Why?
|
| Antibodies, Monoclonal | 10 | 2023 | 9177 | 0.840 |
Why?
|
| Greenhouse Effect | 1 | 2022 | 31 | 0.840 |
Why?
|
| Motor Vehicles | 2 | 2024 | 282 | 0.830 |
Why?
|
| Respiratory Mucosa | 2 | 2020 | 439 | 0.830 |
Why?
|
| Climate | 2 | 2023 | 147 | 0.830 |
Why?
|
| Antibodies, Viral | 14 | 2023 | 3156 | 0.820 |
Why?
|
| Complement Activation | 1 | 2024 | 445 | 0.810 |
Why?
|
| Epigenomics | 3 | 2020 | 943 | 0.810 |
Why?
|
| Adolescent | 79 | 2024 | 88319 | 0.810 |
Why?
|
| Heat-Shock Response | 1 | 2023 | 179 | 0.790 |
Why?
|
| Dendritic Cells | 9 | 2021 | 2747 | 0.780 |
Why?
|
| B-Lymphocytes | 13 | 2024 | 4758 | 0.780 |
Why?
|
| Autoimmune Diseases | 6 | 2023 | 2244 | 0.770 |
Why?
|
| Premature Birth | 2 | 2024 | 1782 | 0.770 |
Why?
|
| Excipients | 1 | 2021 | 98 | 0.760 |
Why?
|
| Carbon Monoxide | 3 | 2021 | 547 | 0.750 |
Why?
|
| Child, Preschool | 49 | 2024 | 42230 | 0.750 |
Why?
|
| 2S Albumins, Plant | 7 | 2023 | 37 | 0.750 |
Why?
|
| Schools, Medical | 2 | 2021 | 879 | 0.750 |
Why?
|
| Esophagus | 3 | 2013 | 1033 | 0.740 |
Why?
|
| Supreme Court Decisions | 1 | 2022 | 133 | 0.740 |
Why?
|
| Public Health | 4 | 2023 | 2669 | 0.730 |
Why?
|
| United Nations | 1 | 2021 | 150 | 0.730 |
Why?
|
| Water Pollutants, Chemical | 2 | 2022 | 359 | 0.720 |
Why?
|
| Eczema | 2 | 2020 | 246 | 0.710 |
Why?
|
| T-Lymphocytes | 17 | 2024 | 10194 | 0.700 |
Why?
|
| Female | 141 | 2024 | 392644 | 0.700 |
Why?
|
| Inhalation Exposure | 2 | 2021 | 432 | 0.700 |
Why?
|
| Lymphocytes | 6 | 2024 | 2612 | 0.690 |
Why?
|
| Infant | 41 | 2024 | 36192 | 0.690 |
Why?
|
| Federal Government | 1 | 2022 | 267 | 0.690 |
Why?
|
| HLA-A2 Antigen | 1 | 2020 | 211 | 0.690 |
Why?
|
| Skin | 9 | 2024 | 4484 | 0.690 |
Why?
|
| Immunologic Tests | 3 | 2020 | 104 | 0.680 |
Why?
|
| Immunophenotyping | 7 | 2024 | 1870 | 0.680 |
Why?
|
| Animals | 98 | 2024 | 168459 | 0.680 |
Why?
|
| Immunologic Factors | 8 | 2023 | 1589 | 0.670 |
Why?
|
| Laboratories | 1 | 2023 | 458 | 0.670 |
Why?
|
| Double-Blind Method | 24 | 2022 | 12341 | 0.650 |
Why?
|
| Milk | 3 | 2019 | 443 | 0.650 |
Why?
|
| California | 8 | 2021 | 1429 | 0.650 |
Why?
|
| Enterocolitis | 1 | 2020 | 106 | 0.640 |
Why?
|
| Cross Reactions | 5 | 2021 | 817 | 0.630 |
Why?
|
| Vaccines | 3 | 2023 | 844 | 0.630 |
Why?
|
| Male | 140 | 2024 | 360804 | 0.630 |
Why?
|
| Environment | 3 | 2023 | 1123 | 0.620 |
Why?
|
| Fungi | 1 | 2021 | 338 | 0.620 |
Why?
|
| Asthma, Exercise-Induced | 1 | 2018 | 23 | 0.610 |
Why?
|
| Adult | 92 | 2024 | 221177 | 0.610 |
Why?
|
| Egg Proteins, Dietary | 1 | 2017 | 6 | 0.600 |
Why?
|
| Air Pollution, Indoor | 3 | 2024 | 901 | 0.590 |
Why?
|
| Fires | 1 | 2019 | 171 | 0.590 |
Why?
|
| Skin Tests | 8 | 2020 | 637 | 0.580 |
Why?
|
| Detergents | 3 | 2023 | 236 | 0.570 |
Why?
|
| Young Adult | 52 | 2024 | 59243 | 0.550 |
Why?
|
| Lymphocyte Activation | 11 | 2017 | 5486 | 0.530 |
Why?
|
| Twins, Monozygotic | 4 | 2019 | 470 | 0.530 |
Why?
|
| Maternal Exposure | 4 | 2024 | 1067 | 0.530 |
Why?
|
| Cadmium | 1 | 2017 | 214 | 0.520 |
Why?
|
| Immunity | 2 | 2021 | 996 | 0.520 |
Why?
|
| Biological Therapy | 1 | 2017 | 141 | 0.510 |
Why?
|
| Anacardium | 3 | 2023 | 6 | 0.510 |
Why?
|
| Polyethylene Glycols | 1 | 2021 | 1189 | 0.510 |
Why?
|
| Rhinitis | 4 | 2023 | 747 | 0.510 |
Why?
|
| Monocytes | 7 | 2023 | 2570 | 0.500 |
Why?
|
| Medical Informatics | 1 | 2022 | 733 | 0.500 |
Why?
|
| Blood Pressure | 3 | 2021 | 8481 | 0.500 |
Why?
|
| Lectins, C-Type | 4 | 2023 | 585 | 0.500 |
Why?
|
| Severe Combined Immunodeficiency | 3 | 2015 | 227 | 0.500 |
Why?
|
| Schools | 1 | 2024 | 1489 | 0.490 |
Why?
|
| Fetal Blood | 4 | 2021 | 1347 | 0.490 |
Why?
|
| Gastroesophageal Reflux | 3 | 2013 | 819 | 0.490 |
Why?
|
| Epinephrine | 3 | 2023 | 792 | 0.490 |
Why?
|
| Antigen-Presenting Cells | 2 | 2021 | 964 | 0.470 |
Why?
|
| Epithelial Cells | 9 | 2024 | 3673 | 0.470 |
Why?
|
| Phleum | 2 | 2020 | 5 | 0.460 |
Why?
|
| Histones | 1 | 2024 | 2580 | 0.460 |
Why?
|
| Sympathomimetics | 1 | 2013 | 56 | 0.440 |
Why?
|
| Epitope Mapping | 4 | 2022 | 298 | 0.440 |
Why?
|
| Research | 4 | 2019 | 1982 | 0.430 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2014 | 2803 | 0.430 |
Why?
|
| Mast Cells | 5 | 2022 | 1392 | 0.430 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2024 | 819 | 0.420 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 4 | 2024 | 3204 | 0.420 |
Why?
|
| HLA-DR Antigens | 2 | 2015 | 602 | 0.420 |
Why?
|
| Peptides | 5 | 2023 | 4358 | 0.420 |
Why?
|
| Common Variable Immunodeficiency | 2 | 2015 | 101 | 0.410 |
Why?
|
| Mites | 1 | 2012 | 46 | 0.410 |
Why?
|
| Interferon-gamma | 10 | 2022 | 3162 | 0.410 |
Why?
|
| Infant, Newborn | 14 | 2024 | 26198 | 0.410 |
Why?
|
| Severity of Illness Index | 14 | 2022 | 15842 | 0.410 |
Why?
|
| Immunologic Memory | 6 | 2021 | 1359 | 0.410 |
Why?
|
| Basophil Degranulation Test | 3 | 2023 | 20 | 0.410 |
Why?
|
| Interleukin-7 Receptor alpha Subunit | 2 | 2009 | 50 | 0.400 |
Why?
|
| Pregnancy | 20 | 2024 | 29874 | 0.400 |
Why?
|
| Ribosomal Protein S6 | 1 | 2012 | 71 | 0.400 |
Why?
|
| Intestinal Mucosa | 4 | 2023 | 3032 | 0.400 |
Why?
|
| Immunity, Cellular | 3 | 2021 | 1560 | 0.400 |
Why?
|
| Seed Storage Proteins | 4 | 2021 | 15 | 0.390 |
Why?
|
| Cardiovascular System | 1 | 2019 | 834 | 0.390 |
Why?
|
| Polyendocrinopathies, Autoimmune | 2 | 2011 | 56 | 0.380 |
Why?
|
| Pyrophosphatases | 2 | 2016 | 142 | 0.380 |
Why?
|
| Middle Aged | 56 | 2024 | 220895 | 0.380 |
Why?
|
| Milk Proteins | 3 | 2018 | 163 | 0.380 |
Why?
|
| Proteomics | 9 | 2023 | 3849 | 0.380 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2012 | 113 | 0.380 |
Why?
|
| Computational Biology | 5 | 2021 | 3518 | 0.380 |
Why?
|
| Phosphoric Diester Hydrolases | 2 | 2016 | 201 | 0.370 |
Why?
|
| Paraffin | 2 | 2020 | 36 | 0.360 |
Why?
|
| Delivery of Health Care | 4 | 2023 | 5336 | 0.360 |
Why?
|
| Autoantibodies | 7 | 2023 | 2116 | 0.350 |
Why?
|
| Interleukin-4 | 5 | 2022 | 1149 | 0.350 |
Why?
|
| Heat-Shock Proteins | 5 | 1994 | 795 | 0.350 |
Why?
|
| Picornaviridae Infections | 2 | 2021 | 95 | 0.350 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2021 | 226 | 0.330 |
Why?
|
| Epithelium | 4 | 2024 | 1603 | 0.330 |
Why?
|
| Gastrointestinal Tract | 4 | 2022 | 833 | 0.330 |
Why?
|
| Dust | 1 | 2012 | 487 | 0.330 |
Why?
|
| Receptors, IgE | 3 | 2021 | 375 | 0.330 |
Why?
|
| United States | 23 | 2024 | 72334 | 0.330 |
Why?
|
| Flow Cytometry | 12 | 2024 | 5869 | 0.320 |
Why?
|
| Epitopes | 5 | 2023 | 2503 | 0.320 |
Why?
|
| Nasal Polyps | 2 | 2014 | 395 | 0.320 |
Why?
|
| Chemokines, C | 1 | 2008 | 10 | 0.320 |
Why?
|
| Chemokines | 2 | 2024 | 960 | 0.320 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2019 | 2518 | 0.310 |
Why?
|
| Universities | 1 | 2014 | 993 | 0.310 |
Why?
|
| Cells, Cultured | 13 | 2020 | 18965 | 0.310 |
Why?
|
| Receptors, Immunologic | 4 | 2023 | 1410 | 0.310 |
Why?
|
| Vaccination | 8 | 2024 | 3384 | 0.310 |
Why?
|
| Gene Expression Profiling | 9 | 2024 | 9420 | 0.310 |
Why?
|
| Inflammation | 13 | 2024 | 10773 | 0.300 |
Why?
|
| Fas Ligand Protein | 1 | 2008 | 216 | 0.300 |
Why?
|
| Lung Diseases | 3 | 2018 | 1909 | 0.300 |
Why?
|
| Single-Cell Analysis | 6 | 2024 | 2449 | 0.300 |
Why?
|
| Probiotics | 3 | 2024 | 378 | 0.300 |
Why?
|
| Treatment Outcome | 25 | 2023 | 64680 | 0.290 |
Why?
|
| Hot Temperature | 4 | 2024 | 1440 | 0.290 |
Why?
|
| Graft Rejection | 11 | 2000 | 4445 | 0.290 |
Why?
|
| Quality of Life | 9 | 2023 | 13367 | 0.290 |
Why?
|
| Mercury | 2 | 2021 | 290 | 0.290 |
Why?
|
| Receptors, IgG | 2 | 2020 | 559 | 0.280 |
Why?
|
| Gene Expression | 8 | 2021 | 7581 | 0.280 |
Why?
|
| STAT Transcription Factors | 1 | 2007 | 188 | 0.280 |
Why?
|
| Cell Adhesion Molecules | 5 | 2021 | 1600 | 0.280 |
Why?
|
| Metabolome | 3 | 2024 | 989 | 0.270 |
Why?
|
| Rhinovirus | 4 | 2021 | 203 | 0.270 |
Why?
|
| Neutropenia | 2 | 2009 | 885 | 0.270 |
Why?
|
| Leukocyte Count | 5 | 2022 | 1596 | 0.270 |
Why?
|
| Forced Expiratory Volume | 5 | 2018 | 1814 | 0.270 |
Why?
|
| Administration, Sublingual | 3 | 2019 | 59 | 0.270 |
Why?
|
| Seasons | 2 | 2023 | 1520 | 0.260 |
Why?
|
| Pilot Projects | 9 | 2022 | 8631 | 0.260 |
Why?
|
| Adrenal Cortex Hormones | 4 | 2021 | 1880 | 0.260 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 3 | 2018 | 111 | 0.260 |
Why?
|
| Bronchi | 3 | 2018 | 845 | 0.260 |
Why?
|
| Growth Disorders | 1 | 2011 | 655 | 0.260 |
Why?
|
| Epitopes, T-Lymphocyte | 4 | 2023 | 828 | 0.250 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2012 | 1784 | 0.250 |
Why?
|
| Immunologic Deficiency Syndromes | 3 | 2015 | 547 | 0.250 |
Why?
|
| Phenotype | 12 | 2024 | 16591 | 0.250 |
Why?
|
| Plastics | 2 | 2022 | 117 | 0.250 |
Why?
|
| Seeds | 3 | 2020 | 122 | 0.250 |
Why?
|
| Sinusitis | 2 | 2014 | 991 | 0.250 |
Why?
|
| Mucous Membrane | 3 | 2023 | 659 | 0.240 |
Why?
|
| Metabolomics | 3 | 2024 | 1659 | 0.240 |
Why?
|
| Environmental Health | 2 | 2018 | 290 | 0.240 |
Why?
|
| Disease Susceptibility | 2 | 2024 | 1787 | 0.240 |
Why?
|
| Anti-Asthmatic Agents | 5 | 2021 | 574 | 0.240 |
Why?
|
| Prevalence | 8 | 2021 | 15732 | 0.240 |
Why?
|
| Cattle | 5 | 2021 | 3849 | 0.240 |
Why?
|
| Adaptive Immunity | 4 | 2024 | 726 | 0.240 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2019 | 3205 | 0.240 |
Why?
|
| Aged | 30 | 2024 | 169289 | 0.240 |
Why?
|
| Parents | 1 | 2018 | 3563 | 0.240 |
Why?
|
| Permeability | 3 | 2023 | 723 | 0.240 |
Why?
|
| Propane | 1 | 2024 | 12 | 0.240 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2022 | 2057 | 0.240 |
Why?
|
| Benzo(a)pyrene | 1 | 2024 | 27 | 0.240 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2008 | 1351 | 0.230 |
Why?
|
| Glycoproteins | 5 | 2023 | 2203 | 0.230 |
Why?
|
| Juglans | 2 | 2017 | 45 | 0.230 |
Why?
|
| Nuts | 3 | 2020 | 264 | 0.230 |
Why?
|
| Kidney Transplantation | 11 | 2000 | 4234 | 0.230 |
Why?
|
| Emigration and Immigration | 2 | 1997 | 397 | 0.230 |
Why?
|
| Antigens | 2 | 2024 | 1443 | 0.230 |
Why?
|
| Interleukin-13 | 4 | 2023 | 392 | 0.220 |
Why?
|
| Histone Code | 1 | 2024 | 158 | 0.220 |
Why?
|
| Tight Junctions | 3 | 2024 | 324 | 0.220 |
Why?
|
| Polysorbates | 1 | 2023 | 44 | 0.220 |
Why?
|
| Pregnancy Outcome | 3 | 2023 | 2921 | 0.220 |
Why?
|
| Electricity | 1 | 2024 | 181 | 0.220 |
Why?
|
| Amino Acid Substitution | 1 | 2008 | 1738 | 0.220 |
Why?
|
| NADH, NADPH Oxidoreductases | 3 | 1992 | 94 | 0.220 |
Why?
|
| Antigens, Surface | 1 | 2007 | 1606 | 0.220 |
Why?
|
| Adenosine Triphosphatases | 5 | 1994 | 835 | 0.220 |
Why?
|
| West Virginia | 1 | 2022 | 31 | 0.210 |
Why?
|
| Guanidines | 2 | 1994 | 194 | 0.210 |
Why?
|
| Recycling | 1 | 2022 | 16 | 0.210 |
Why?
|
| Reference Standards | 3 | 2018 | 1003 | 0.210 |
Why?
|
| Leukotriene B4 | 1 | 2024 | 280 | 0.210 |
Why?
|
| Receptors, Interleukin-2 | 4 | 2022 | 562 | 0.210 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2021 | 17904 | 0.210 |
Why?
|
| Antibodies, Neutralizing | 6 | 2022 | 1943 | 0.210 |
Why?
|
| Advisory Committees | 2 | 2019 | 787 | 0.210 |
Why?
|
| Monkeypox virus | 1 | 2023 | 42 | 0.210 |
Why?
|
| STAT6 Transcription Factor | 2 | 2014 | 194 | 0.210 |
Why?
|
| Volatile Organic Compounds | 1 | 2024 | 86 | 0.210 |
Why?
|
| Rats, Inbred Lew | 18 | 2024 | 1157 | 0.210 |
Why?
|
| Mass Spectrometry | 2 | 2020 | 2192 | 0.210 |
Why?
|
| Coronavirus Infections | 4 | 2020 | 3084 | 0.210 |
Why?
|
| Antigens, CD | 9 | 2018 | 4003 | 0.210 |
Why?
|
| Mice | 23 | 2024 | 81525 | 0.210 |
Why?
|
| Pneumonia, Viral | 4 | 2020 | 3204 | 0.200 |
Why?
|
| Tetanus | 1 | 2022 | 51 | 0.200 |
Why?
|
| Inheritance Patterns | 1 | 2024 | 341 | 0.200 |
Why?
|
| Avidin | 2 | 2023 | 43 | 0.200 |
Why?
|
| Placenta | 3 | 2023 | 1709 | 0.200 |
Why?
|
| Twins | 2 | 2021 | 339 | 0.200 |
Why?
|
| United States Environmental Protection Agency | 1 | 2022 | 139 | 0.200 |
Why?
|
| Hypertension, Pulmonary | 3 | 2024 | 1578 | 0.200 |
Why?
|
| Crithidia fasciculata | 4 | 1998 | 4 | 0.200 |
Why?
|
| United States Food and Drug Administration | 2 | 2021 | 1664 | 0.200 |
Why?
|
| Body Fluids | 1 | 2024 | 320 | 0.200 |
Why?
|
| Immunoglobulin A | 3 | 2022 | 978 | 0.200 |
Why?
|
| Th17 Cells | 3 | 2021 | 794 | 0.200 |
Why?
|
| Soil | 1 | 2022 | 115 | 0.200 |
Why?
|
| Power Plants | 1 | 2022 | 124 | 0.200 |
Why?
|
| Comorbidity | 7 | 2022 | 10508 | 0.200 |
Why?
|
| United States Dept. of Health and Human Services | 1 | 2022 | 88 | 0.190 |
Why?
|
| Enteritis | 1 | 2023 | 162 | 0.190 |
Why?
|
| Smoke | 1 | 2023 | 235 | 0.190 |
Why?
|
| Immunosuppressive Agents | 8 | 2014 | 4174 | 0.190 |
Why?
|
| Respiratory Tract Diseases | 2 | 2019 | 750 | 0.190 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2024 | 1974 | 0.190 |
Why?
|
| Convalescence | 1 | 2021 | 105 | 0.190 |
Why?
|
| Nasal Obstruction | 1 | 2023 | 160 | 0.190 |
Why?
|
| Clinical Trials as Topic | 7 | 2022 | 8002 | 0.190 |
Why?
|
| Spores, Fungal | 1 | 2021 | 90 | 0.190 |
Why?
|
| Placebos | 3 | 2021 | 1667 | 0.190 |
Why?
|
| Autoantigens | 4 | 2023 | 891 | 0.190 |
Why?
|
| Artificial Intelligence | 3 | 2024 | 2578 | 0.180 |
Why?
|
| Wiskott-Aldrich Syndrome Protein | 2 | 2012 | 161 | 0.180 |
Why?
|
| Disease Models, Animal | 8 | 2024 | 18252 | 0.180 |
Why?
|
| Pistacia | 1 | 2020 | 7 | 0.180 |
Why?
|
| Academies and Institutes | 2 | 2020 | 318 | 0.180 |
Why?
|
| Petrolatum | 1 | 2020 | 7 | 0.180 |
Why?
|
| Expert Testimony | 2 | 2020 | 364 | 0.180 |
Why?
|
| Nitrogen Oxides | 1 | 2020 | 129 | 0.180 |
Why?
|
| Medical History Taking | 2 | 2015 | 774 | 0.180 |
Why?
|
| Education, Medical | 2 | 2023 | 1725 | 0.180 |
Why?
|
| Cells | 1 | 2021 | 165 | 0.180 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2020 | 91 | 0.180 |
Why?
|
| Mass Vaccination | 1 | 2021 | 109 | 0.180 |
Why?
|
| Pandemics | 9 | 2022 | 8654 | 0.180 |
Why?
|
| Phosphorylation | 6 | 2012 | 8320 | 0.170 |
Why?
|
| Trees | 1 | 2020 | 55 | 0.170 |
Why?
|
| Vital Capacity | 3 | 2018 | 971 | 0.170 |
Why?
|
| Curriculum | 3 | 2023 | 3743 | 0.170 |
Why?
|
| Genes, Immunoglobulin Heavy Chain | 2 | 2010 | 57 | 0.170 |
Why?
|
| Chemokine CCL1 | 2 | 2010 | 20 | 0.170 |
Why?
|
| Pyroglyphidae | 2 | 2019 | 89 | 0.170 |
Why?
|
| Cats | 1 | 2021 | 975 | 0.170 |
Why?
|
| Mutation | 14 | 2020 | 30052 | 0.170 |
Why?
|
| Cell Degranulation | 1 | 2020 | 277 | 0.170 |
Why?
|
| Triticum | 2 | 2018 | 90 | 0.170 |
Why?
|
| Azetidines | 1 | 2020 | 142 | 0.170 |
Why?
|
| Diet | 4 | 2023 | 8075 | 0.170 |
Why?
|
| Vaccines, Synthetic | 4 | 2023 | 616 | 0.170 |
Why?
|
| Cardiovascular Diseases | 3 | 2020 | 15500 | 0.170 |
Why?
|
| Immunoconjugates | 5 | 1998 | 954 | 0.170 |
Why?
|
| Knowledge | 1 | 2021 | 177 | 0.170 |
Why?
|
| Cell Movement | 2 | 2010 | 5203 | 0.160 |
Why?
|
| Intercellular Adhesion Molecule-1 | 5 | 2020 | 1126 | 0.160 |
Why?
|
| Cyclosporine | 5 | 1998 | 778 | 0.160 |
Why?
|
| Health Policy | 2 | 2024 | 2684 | 0.160 |
Why?
|
| Alanine | 2 | 2020 | 609 | 0.160 |
Why?
|
| Adenosine Monophosphate | 1 | 2020 | 231 | 0.160 |
Why?
|
| Spermidine | 3 | 1998 | 62 | 0.160 |
Why?
|
| World Health Organization | 2 | 2023 | 1322 | 0.160 |
Why?
|
| Germinal Center | 1 | 2022 | 380 | 0.160 |
Why?
|
| Wheat Hypersensitivity | 1 | 2018 | 11 | 0.160 |
Why?
|
| New Hampshire | 2 | 2019 | 175 | 0.160 |
Why?
|
| Tumor Necrosis Factor-alpha | 7 | 2020 | 4352 | 0.160 |
Why?
|
| Coronavirus | 1 | 2021 | 154 | 0.160 |
Why?
|
| CD40 Ligand | 1 | 2000 | 522 | 0.160 |
Why?
|
| Vulnerable Populations | 1 | 2024 | 703 | 0.150 |
Why?
|
| Environmental Policy | 1 | 2018 | 35 | 0.150 |
Why?
|
| Factor VIII | 1 | 2000 | 348 | 0.150 |
Why?
|
| DNA | 2 | 2015 | 7212 | 0.150 |
Why?
|
| Twins, Dizygotic | 2 | 2019 | 236 | 0.150 |
Why?
|
| Agglutination | 1 | 2017 | 41 | 0.150 |
Why?
|
| Cross-Sectional Studies | 8 | 2022 | 26125 | 0.150 |
Why?
|
| Oxidative Stress | 4 | 2024 | 3113 | 0.150 |
Why?
|
| Diet, Reducing | 1 | 2021 | 485 | 0.150 |
Why?
|
| Hospitalization | 7 | 2023 | 10723 | 0.150 |
Why?
|
| Antibody Affinity | 1 | 2018 | 246 | 0.150 |
Why?
|
| Environmental Monitoring | 2 | 2022 | 1460 | 0.150 |
Why?
|
| Perforin | 2 | 2008 | 167 | 0.150 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2021 | 494 | 0.150 |
Why?
|
| Receptors, Interleukin-13 | 1 | 2017 | 13 | 0.150 |
Why?
|
| Eosinophilia | 2 | 2021 | 560 | 0.150 |
Why?
|
| Receptors, Interleukin-5 | 1 | 2017 | 20 | 0.150 |
Why?
|
| Feces | 2 | 2022 | 1497 | 0.150 |
Why?
|
| Chemokine CCL5 | 4 | 1997 | 214 | 0.150 |
Why?
|
| Research Support as Topic | 1 | 2022 | 697 | 0.140 |
Why?
|
| Case-Control Studies | 9 | 2021 | 22176 | 0.140 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2018 | 239 | 0.140 |
Why?
|
| Egg Proteins | 1 | 2017 | 57 | 0.140 |
Why?
|
| Monitoring, Immunologic | 1 | 2017 | 98 | 0.140 |
Why?
|
| Feedback | 1 | 2021 | 791 | 0.140 |
Why?
|
| Purines | 1 | 2020 | 607 | 0.140 |
Why?
|
| Gene Regulatory Networks | 2 | 2024 | 1745 | 0.140 |
Why?
|
| Gene Expression Regulation | 9 | 2021 | 11903 | 0.140 |
Why?
|
| Risk Factors | 9 | 2021 | 74206 | 0.140 |
Why?
|
| Immunoglobulin Heavy Chains | 2 | 2021 | 647 | 0.140 |
Why?
|
| Interleukin-4 Receptor alpha Subunit | 1 | 2017 | 57 | 0.140 |
Why?
|
| Glutathione | 4 | 1998 | 583 | 0.140 |
Why?
|
| Cannabis | 1 | 2023 | 441 | 0.140 |
Why?
|
| Endothelial Cells | 2 | 2020 | 3548 | 0.140 |
Why?
|
| Reperfusion Injury | 7 | 1997 | 1023 | 0.140 |
Why?
|
| Disasters | 1 | 2023 | 519 | 0.140 |
Why?
|
| Up-Regulation | 6 | 2022 | 4124 | 0.140 |
Why?
|
| Metabolic Diseases | 1 | 2023 | 683 | 0.140 |
Why?
|
| Health Facilities | 1 | 2022 | 580 | 0.140 |
Why?
|
| Viral Vaccines | 1 | 2022 | 596 | 0.140 |
Why?
|
| Drug Eruptions | 1 | 2020 | 335 | 0.140 |
Why?
|
| Carya | 1 | 2016 | 2 | 0.140 |
Why?
|
| Interleukin-7 | 2 | 2021 | 143 | 0.140 |
Why?
|
| Athletes | 1 | 2024 | 1137 | 0.140 |
Why?
|
| Awareness | 1 | 2021 | 648 | 0.140 |
Why?
|
| Trypanosoma cruzi | 3 | 1994 | 206 | 0.140 |
Why?
|
| Adolescent Development | 1 | 2020 | 282 | 0.140 |
Why?
|
| Chemotaxis | 2 | 2010 | 598 | 0.130 |
Why?
|
| Immunoglobulins | 1 | 2019 | 853 | 0.130 |
Why?
|
| Antigens, Dermatophagoides | 1 | 2016 | 98 | 0.130 |
Why?
|
| Killer Cells, Natural | 2 | 2022 | 2200 | 0.130 |
Why?
|
| Neutrophils | 3 | 2022 | 3767 | 0.130 |
Why?
|
| Nuclear Proteins | 3 | 2015 | 5796 | 0.130 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2020 | 699 | 0.130 |
Why?
|
| Molecular Mimicry | 1 | 2017 | 213 | 0.130 |
Why?
|
| Gliadin | 1 | 2016 | 80 | 0.130 |
Why?
|
| Child Welfare | 2 | 2017 | 521 | 0.130 |
Why?
|
| Signal Transduction | 6 | 2022 | 23445 | 0.130 |
Why?
|
| Methylation | 2 | 2020 | 1084 | 0.130 |
Why?
|
| Antibody Formation | 4 | 2022 | 1395 | 0.130 |
Why?
|
| Policy Making | 1 | 2019 | 542 | 0.130 |
Why?
|
| Molecular Targeted Therapy | 2 | 2017 | 2811 | 0.130 |
Why?
|
| Thinking | 1 | 2019 | 320 | 0.130 |
Why?
|
| RNA | 4 | 2023 | 2726 | 0.130 |
Why?
|
| Glycosylation | 2 | 2024 | 1098 | 0.130 |
Why?
|
| Pulmonary Artery | 1 | 2024 | 1927 | 0.130 |
Why?
|
| Conjunctivitis, Allergic | 1 | 2016 | 125 | 0.130 |
Why?
|
| Confidence Intervals | 1 | 2021 | 2927 | 0.130 |
Why?
|
| Growth Substances | 2 | 1997 | 768 | 0.130 |
Why?
|
| Stress, Physiological | 1 | 2023 | 1403 | 0.130 |
Why?
|
| Pathology, Molecular | 1 | 2018 | 328 | 0.130 |
Why?
|
| RNA, Messenger | 9 | 2022 | 12795 | 0.120 |
Why?
|
| Trypanosoma | 2 | 1992 | 16 | 0.120 |
Why?
|
| Nails | 1 | 2017 | 296 | 0.120 |
Why?
|
| Government Regulation | 1 | 2019 | 524 | 0.120 |
Why?
|
| Feasibility Studies | 3 | 2022 | 5247 | 0.120 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 746 | 0.120 |
Why?
|
| Chronic Disease | 5 | 2023 | 9318 | 0.120 |
Why?
|
| Antioxidants | 1 | 2023 | 1668 | 0.120 |
Why?
|
| Introns | 1 | 2018 | 981 | 0.120 |
Why?
|
| Educational Status | 1 | 2022 | 2522 | 0.120 |
Why?
|
| Chemokine CCL2 | 3 | 1997 | 605 | 0.120 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2015 | 112 | 0.120 |
Why?
|
| Life Style | 2 | 2024 | 3917 | 0.120 |
Why?
|
| Kidney | 12 | 2000 | 7048 | 0.120 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2015 | 173 | 0.120 |
Why?
|
| HLA-DQ Antigens | 1 | 2015 | 191 | 0.120 |
Why?
|
| Immunomodulation | 2 | 2019 | 549 | 0.120 |
Why?
|
| Mycophenolic Acid | 1 | 1996 | 348 | 0.120 |
Why?
|
| Immunoglobulin Variable Region | 2 | 2018 | 419 | 0.120 |
Why?
|
| Bacterial Infections | 1 | 2022 | 1390 | 0.120 |
Why?
|
| Antiprotozoal Agents | 2 | 1992 | 94 | 0.120 |
Why?
|
| Genome-Wide Association Study | 6 | 2022 | 12690 | 0.120 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2015 | 322 | 0.110 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2024 | 2244 | 0.110 |
Why?
|
| Respiratory Tract Infections | 1 | 2022 | 1010 | 0.110 |
Why?
|
| Calpain | 1 | 2014 | 146 | 0.110 |
Why?
|
| Patient-Centered Care | 1 | 2024 | 1421 | 0.110 |
Why?
|
| Physician's Role | 1 | 2021 | 917 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 5 | 2017 | 6075 | 0.110 |
Why?
|
| Systems Biology | 1 | 2018 | 481 | 0.110 |
Why?
|
| Amino Acid Sequence | 9 | 2022 | 13446 | 0.110 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2023 | 2865 | 0.110 |
Why?
|
| Clone Cells | 2 | 2015 | 1659 | 0.110 |
Why?
|
| Immunoglobulin M | 2 | 2024 | 1527 | 0.110 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2015 | 292 | 0.110 |
Why?
|
| Macrophages | 7 | 2021 | 5769 | 0.110 |
Why?
|
| Water | 1 | 2020 | 1411 | 0.110 |
Why?
|
| Patient Care | 1 | 2019 | 622 | 0.110 |
Why?
|
| Consensus Sequence | 1 | 2014 | 365 | 0.110 |
Why?
|
| Amino Acid Isomerases | 1 | 1993 | 31 | 0.110 |
Why?
|
| Bacteria | 2 | 2022 | 2199 | 0.110 |
Why?
|
| History, 21st Century | 1 | 2019 | 1567 | 0.110 |
Why?
|
| Medicine | 1 | 2021 | 942 | 0.110 |
Why?
|
| Hyaluronic Acid | 1 | 2017 | 483 | 0.110 |
Why?
|
| Glycosyltransferases | 1 | 2024 | 117 | 0.110 |
Why?
|
| Intestinal Atresia | 1 | 2013 | 68 | 0.110 |
Why?
|
| Diet, Fat-Restricted | 1 | 2015 | 329 | 0.110 |
Why?
|
| Rats | 21 | 2024 | 23742 | 0.110 |
Why?
|
| Granuloma | 1 | 2015 | 328 | 0.100 |
Why?
|
| Urban Population | 1 | 2021 | 2036 | 0.100 |
Why?
|
| HLA Antigens | 3 | 2021 | 1328 | 0.100 |
Why?
|
| Diphtheria Toxin | 1 | 2013 | 253 | 0.100 |
Why?
|
| Liver Failure, Acute | 1 | 2014 | 181 | 0.100 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2014 | 435 | 0.100 |
Why?
|
| Hepatitis | 1 | 2014 | 228 | 0.100 |
Why?
|
| Transcription Factors | 4 | 2015 | 12128 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 4575 | 0.100 |
Why?
|
| Disease Progression | 5 | 2024 | 13506 | 0.100 |
Why?
|
| Body Composition | 1 | 2021 | 2426 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 4 | 2018 | 5789 | 0.100 |
Why?
|
| P-Selectin | 4 | 1998 | 597 | 0.100 |
Why?
|
| Primary Prevention | 1 | 2019 | 1186 | 0.100 |
Why?
|
| Injections, Intramuscular | 1 | 2013 | 554 | 0.100 |
Why?
|
| Transplantation, Homologous | 9 | 2000 | 4806 | 0.100 |
Why?
|
| Predictive Value of Tests | 3 | 2020 | 15266 | 0.100 |
Why?
|
| Isoantibodies | 2 | 2009 | 674 | 0.100 |
Why?
|
| Nasal Mucosa | 2 | 2016 | 416 | 0.100 |
Why?
|
| Receptors, Cell Surface | 1 | 2021 | 2822 | 0.100 |
Why?
|
| Echocardiography | 1 | 2024 | 4989 | 0.100 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 1994 | 397 | 0.100 |
Why?
|
| Dietary Fiber | 1 | 2015 | 759 | 0.100 |
Why?
|
| Specimen Handling | 1 | 2016 | 702 | 0.100 |
Why?
|
| X-Linked Combined Immunodeficiency Diseases | 1 | 2011 | 24 | 0.100 |
Why?
|
| Proteome | 1 | 2021 | 1862 | 0.100 |
Why?
|
| Aged, 80 and over | 7 | 2024 | 58976 | 0.100 |
Why?
|
| Antiviral Agents | 2 | 2021 | 3060 | 0.100 |
Why?
|
| History, 20th Century | 1 | 2019 | 2767 | 0.100 |
Why?
|
| bcl-X Protein | 1 | 2013 | 410 | 0.100 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2015 | 800 | 0.090 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2024 | 2155 | 0.090 |
Why?
|
| Obesity, Abdominal | 1 | 2014 | 374 | 0.090 |
Why?
|
| Drug Therapy, Combination | 2 | 2020 | 6310 | 0.090 |
Why?
|
| Membrane Glycoproteins | 5 | 2023 | 3702 | 0.090 |
Why?
|
| Cell Differentiation | 4 | 2022 | 11528 | 0.090 |
Why?
|
| Vitamin D Deficiency | 1 | 2021 | 1388 | 0.090 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2020 | 1897 | 0.090 |
Why?
|
| Cell Communication | 3 | 2013 | 1657 | 0.090 |
Why?
|
| Sulfonamides | 1 | 2020 | 1978 | 0.090 |
Why?
|
| Serum Amyloid A Protein | 1 | 2011 | 127 | 0.090 |
Why?
|
| Rats, Inbred F344 | 8 | 2000 | 826 | 0.090 |
Why?
|
| Genomics | 3 | 2018 | 5821 | 0.090 |
Why?
|
| Wiskott-Aldrich Syndrome | 1 | 2011 | 131 | 0.090 |
Why?
|
| Gastrointestinal Diseases | 1 | 2019 | 1200 | 0.090 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2014 | 569 | 0.090 |
Why?
|
| Amino Acid Motifs | 3 | 2019 | 931 | 0.090 |
Why?
|
| Base Sequence | 5 | 2014 | 12441 | 0.090 |
Why?
|
| Molecular Sequence Data | 10 | 2018 | 17635 | 0.090 |
Why?
|
| Interleukin-1 | 3 | 2012 | 1248 | 0.090 |
Why?
|
| Dietary Proteins | 1 | 2016 | 952 | 0.090 |
Why?
|
| Asthma, Aspirin-Induced | 1 | 2014 | 202 | 0.090 |
Why?
|
| Complement System Proteins | 1 | 2024 | 736 | 0.090 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2012 | 177 | 0.090 |
Why?
|
| Binding Sites | 3 | 2014 | 6055 | 0.090 |
Why?
|
| Ethmoid Sinus | 1 | 2010 | 57 | 0.090 |
Why?
|
| Membrane Proteins | 4 | 2021 | 7856 | 0.090 |
Why?
|
| High-Throughput Screening Assays | 2 | 2021 | 934 | 0.090 |
Why?
|
| Genetic Association Studies | 2 | 2018 | 2735 | 0.090 |
Why?
|
| Clonal Anergy | 1 | 2011 | 170 | 0.090 |
Why?
|
| Heart Transplantation | 1 | 2024 | 3233 | 0.090 |
Why?
|
| Genome, Human | 2 | 2014 | 4425 | 0.090 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2011 | 159 | 0.090 |
Why?
|
| Pyrazoles | 1 | 2020 | 2009 | 0.090 |
Why?
|
| Drug Approval | 1 | 2017 | 814 | 0.090 |
Why?
|
| Carrier Proteins | 2 | 1994 | 4936 | 0.090 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2011 | 178 | 0.090 |
Why?
|
| Skin Diseases | 1 | 2019 | 1094 | 0.090 |
Why?
|
| Weight Loss | 1 | 2021 | 2684 | 0.090 |
Why?
|
| Age of Onset | 1 | 2017 | 3305 | 0.090 |
Why?
|
| STAT1 Transcription Factor | 1 | 2011 | 341 | 0.090 |
Why?
|
| Attitude to Health | 1 | 2019 | 2025 | 0.090 |
Why?
|
| Behavior Therapy | 1 | 2015 | 879 | 0.080 |
Why?
|
| Cell Count | 2 | 2012 | 1835 | 0.080 |
Why?
|
| GPI-Linked Proteins | 1 | 2011 | 469 | 0.080 |
Why?
|
| Biosensing Techniques | 1 | 2016 | 650 | 0.080 |
Why?
|
| Thrombocytopenia, Neonatal Alloimmune | 1 | 2009 | 19 | 0.080 |
Why?
|
| Transcription, Genetic | 4 | 2021 | 7594 | 0.080 |
Why?
|
| Data Collection | 1 | 2019 | 3322 | 0.080 |
Why?
|
| Prospective Studies | 7 | 2024 | 54425 | 0.080 |
Why?
|
| Vancomycin | 1 | 2012 | 503 | 0.080 |
Why?
|
| Prognosis | 3 | 2018 | 29625 | 0.080 |
Why?
|
| Chemokines, CC | 1 | 2010 | 283 | 0.080 |
Why?
|
| Vitamin D | 2 | 2021 | 3303 | 0.080 |
Why?
|
| Physical Examination | 1 | 2015 | 1255 | 0.080 |
Why?
|
| Receptors, CCR8 | 1 | 2009 | 28 | 0.080 |
Why?
|
| Epoprostenol | 1 | 2010 | 247 | 0.080 |
Why?
|
| Interleukin-5 | 2 | 2021 | 269 | 0.080 |
Why?
|
| Age Factors | 3 | 2021 | 18395 | 0.080 |
Why?
|
| Fluorescent Dyes | 1 | 2017 | 1903 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 5 | 2021 | 3639 | 0.080 |
Why?
|
| Immune Sera | 2 | 2021 | 606 | 0.080 |
Why?
|
| Diagnosis, Differential | 2 | 2015 | 12974 | 0.080 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2023 | 1844 | 0.080 |
Why?
|
| Receptors, CCR4 | 1 | 2009 | 77 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2023 | 10209 | 0.080 |
Why?
|
| Natural Cytotoxicity Triggering Receptor 3 | 1 | 2008 | 14 | 0.080 |
Why?
|
| Chromatin | 1 | 2020 | 2960 | 0.080 |
Why?
|
| C-Reactive Protein | 1 | 2020 | 3826 | 0.080 |
Why?
|
| Genetic Loci | 2 | 2021 | 2632 | 0.080 |
Why?
|
| Natural Cytotoxicity Triggering Receptor 1 | 1 | 2008 | 29 | 0.080 |
Why?
|
| Antigens, Differentiation | 5 | 1998 | 910 | 0.080 |
Why?
|
| Molecular Weight | 4 | 2017 | 2186 | 0.080 |
Why?
|
| Protein Multimerization | 1 | 2014 | 983 | 0.080 |
Why?
|
| Interleukin-1beta | 1 | 2014 | 999 | 0.080 |
Why?
|
| Amiodarone | 1 | 2010 | 217 | 0.080 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2014 | 781 | 0.080 |
Why?
|
| Retrospective Studies | 7 | 2023 | 80636 | 0.080 |
Why?
|
| Healthcare Disparities | 1 | 2024 | 3358 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 4 | 2019 | 4740 | 0.080 |
Why?
|
| Injections, Subcutaneous | 2 | 2020 | 681 | 0.080 |
Why?
|
| Plant Extracts | 1 | 2012 | 498 | 0.080 |
Why?
|
| Poverty | 1 | 2020 | 2698 | 0.080 |
Why?
|
| Child Development | 1 | 2020 | 2306 | 0.080 |
Why?
|
| Drug Hypersensitivity | 1 | 2017 | 917 | 0.080 |
Why?
|
| Child Abuse | 1 | 1997 | 1077 | 0.080 |
Why?
|
| Pregnancy Complications | 1 | 2022 | 2947 | 0.070 |
Why?
|
| HL-60 Cells | 1 | 2008 | 363 | 0.070 |
Why?
|
| Steroids | 2 | 2023 | 929 | 0.070 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2008 | 133 | 0.070 |
Why?
|
| Multivariate Analysis | 1 | 2021 | 12059 | 0.070 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 1756 | 0.070 |
Why?
|
| Family | 2 | 2019 | 3194 | 0.070 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily B | 1 | 2007 | 84 | 0.070 |
Why?
|
| Students, Medical | 1 | 2021 | 1936 | 0.070 |
Why?
|
| Antigens, Viral | 2 | 2022 | 988 | 0.070 |
Why?
|
| NF-kappa B | 3 | 2022 | 2490 | 0.070 |
Why?
|
| Safety | 1 | 2012 | 1150 | 0.070 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2022 | 1039 | 0.070 |
Why?
|
| Antigen Presentation | 1 | 2013 | 1251 | 0.070 |
Why?
|
| Administration, Cutaneous | 2 | 2021 | 713 | 0.070 |
Why?
|
| Chromosome Mapping | 2 | 2014 | 4615 | 0.070 |
Why?
|
| Escherichia coli | 3 | 2022 | 4217 | 0.070 |
Why?
|
| Aging | 3 | 2022 | 8708 | 0.070 |
Why?
|
| Protozoan Proteins | 2 | 1998 | 847 | 0.070 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2009 | 461 | 0.070 |
Why?
|
| Kinetics | 6 | 2021 | 6374 | 0.070 |
Why?
|
| Granzymes | 1 | 2008 | 277 | 0.070 |
Why?
|
| South Africa | 2 | 2023 | 1842 | 0.070 |
Why?
|
| Telemedicine | 1 | 2024 | 3051 | 0.070 |
Why?
|
| Dietary Supplements | 1 | 2019 | 3415 | 0.070 |
Why?
|
| Time Factors | 6 | 2020 | 39967 | 0.070 |
Why?
|
| Codon, Nonsense | 1 | 2008 | 285 | 0.070 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2021 | 611 | 0.070 |
Why?
|
| Sequence Alignment | 3 | 2019 | 2180 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2021 | 5079 | 0.070 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 615 | 0.070 |
Why?
|
| Amide Synthases | 2 | 1998 | 14 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2021 | 4016 | 0.070 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 2416 | 0.070 |
Why?
|
| Infusions, Intravenous | 1 | 2021 | 2219 | 0.070 |
Why?
|
| Saccharomyces cerevisiae | 3 | 1998 | 2688 | 0.070 |
Why?
|
| Risk Assessment | 2 | 2020 | 23995 | 0.060 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2010 | 774 | 0.060 |
Why?
|
| DNA Copy Number Variations | 1 | 2014 | 2020 | 0.060 |
Why?
|
| Graft Survival | 1 | 1996 | 3819 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2011 | 2919 | 0.060 |
Why?
|
| Respiration, Artificial | 2 | 2021 | 2628 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 4 | 2017 | 1741 | 0.060 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2013 | 1934 | 0.060 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 39106 | 0.060 |
Why?
|
| Cell Separation | 1 | 2010 | 1720 | 0.060 |
Why?
|
| Sirolimus | 1 | 2012 | 1533 | 0.060 |
Why?
|
| Treatment Failure | 1 | 2021 | 2645 | 0.060 |
Why?
|
| Adiposity | 1 | 2014 | 1878 | 0.060 |
Why?
|
| Canada | 2 | 2020 | 2122 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2273 | 0.060 |
Why?
|
| Education | 2 | 2019 | 537 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 4 | 2024 | 7390 | 0.060 |
Why?
|
| Intestines | 1 | 2013 | 1909 | 0.060 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2010 | 2571 | 0.060 |
Why?
|
| Viral Proteins | 2 | 2021 | 1804 | 0.060 |
Why?
|
| Quality Improvement | 1 | 2019 | 3801 | 0.060 |
Why?
|
| Spleen | 3 | 2021 | 2295 | 0.060 |
Why?
|
| Health Status | 1 | 1997 | 4077 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 6 | 2023 | 22169 | 0.060 |
Why?
|
| Repressor Proteins | 1 | 2014 | 2986 | 0.060 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2024 | 93 | 0.050 |
Why?
|
| Neointima | 1 | 2024 | 133 | 0.050 |
Why?
|
| RNA, Viral | 2 | 2022 | 2846 | 0.050 |
Why?
|
| Biopsy | 2 | 2014 | 6766 | 0.050 |
Why?
|
| Irritants | 1 | 2023 | 43 | 0.050 |
Why?
|
| Macadamia | 1 | 2022 | 1 | 0.050 |
Why?
|
| Reproducibility of Results | 4 | 2023 | 20098 | 0.050 |
Why?
|
| Pulsatile Flow | 1 | 2024 | 321 | 0.050 |
Why?
|
| Cytophotometry | 1 | 2022 | 8 | 0.050 |
Why?
|
| Pneumonia | 2 | 2017 | 2143 | 0.050 |
Why?
|
| Receptors, CCR7 | 1 | 2023 | 107 | 0.050 |
Why?
|
| Cohort Studies | 5 | 2022 | 41487 | 0.050 |
Why?
|
| Turbinates | 1 | 2023 | 65 | 0.050 |
Why?
|
| Psoriasis | 1 | 2011 | 950 | 0.050 |
Why?
|
| Breast Feeding | 2 | 2021 | 1359 | 0.050 |
Why?
|
| Trypanosoma congolense | 2 | 1992 | 3 | 0.050 |
Why?
|
| Selenomethionine | 1 | 2022 | 18 | 0.050 |
Why?
|
| Hospital Mortality | 2 | 2021 | 5294 | 0.050 |
Why?
|
| Aspirin | 1 | 2014 | 3133 | 0.050 |
Why?
|
| Immunodominant Epitopes | 1 | 2023 | 239 | 0.050 |
Why?
|
| Mass Screening | 1 | 2018 | 5428 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 3617 | 0.050 |
Why?
|
| Apoptosis | 3 | 2018 | 9486 | 0.050 |
Why?
|
| Obesity | 2 | 2021 | 12947 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2011 | 2425 | 0.050 |
Why?
|
| Longitudinal Studies | 3 | 2021 | 14605 | 0.050 |
Why?
|
| Receptors, KIR | 1 | 2022 | 110 | 0.050 |
Why?
|
| Tetanus Toxoid | 1 | 2022 | 189 | 0.050 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2022 | 158 | 0.050 |
Why?
|
| Mongolia | 1 | 2021 | 93 | 0.050 |
Why?
|
| Cooking | 1 | 2024 | 315 | 0.050 |
Why?
|
| Cullin Proteins | 1 | 2022 | 179 | 0.050 |
Why?
|
| Administration, Topical | 1 | 2023 | 704 | 0.050 |
Why?
|
| Hypertrophy | 1 | 2023 | 561 | 0.050 |
Why?
|
| Reference Values | 2 | 2024 | 4920 | 0.050 |
Why?
|
| Immunoglobulin D | 1 | 2021 | 54 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2011 | 2872 | 0.050 |
Why?
|
| Leishmania | 2 | 1992 | 75 | 0.050 |
Why?
|
| Pesticides | 1 | 2024 | 296 | 0.050 |
Why?
|
| Sesamum | 1 | 2020 | 20 | 0.050 |
Why?
|
| Lung | 2 | 2023 | 10000 | 0.050 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2021 | 101 | 0.050 |
Why?
|
| Immunogenetics | 1 | 2020 | 62 | 0.050 |
Why?
|
| Homeostasis | 2 | 2022 | 3323 | 0.040 |
Why?
|
| Combined Modality Therapy | 3 | 2017 | 8529 | 0.040 |
Why?
|
| Diet Therapy | 1 | 2021 | 151 | 0.040 |
Why?
|
| Epidermis | 1 | 2023 | 528 | 0.040 |
Why?
|
| DNA-Binding Proteins | 2 | 2015 | 9606 | 0.040 |
Why?
|
| Critical Pathways | 1 | 2024 | 474 | 0.040 |
Why?
|
| Austria | 1 | 2020 | 207 | 0.040 |
Why?
|
| Antihypertensive Agents | 1 | 2010 | 2024 | 0.040 |
Why?
|
| Infant Food | 1 | 2021 | 140 | 0.040 |
Why?
|
| Spirometry | 2 | 2014 | 929 | 0.040 |
Why?
|
| Peptide Library | 1 | 2021 | 347 | 0.040 |
Why?
|
| Genes, Immunoglobulin | 1 | 2021 | 285 | 0.040 |
Why?
|
| Immunity, Mucosal | 1 | 2023 | 483 | 0.040 |
Why?
|
| Health Services Needs and Demand | 2 | 2019 | 1403 | 0.040 |
Why?
|
| Toll-Like Receptors | 2 | 2015 | 589 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 2455 | 0.040 |
Why?
|
| Antibodies, Antinuclear | 1 | 2021 | 343 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2022 | 347 | 0.040 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 2020 | 83 | 0.040 |
Why?
|
| Sequence Analysis | 1 | 2020 | 240 | 0.040 |
Why?
|
| Ferrosoferric Oxide | 1 | 2021 | 348 | 0.040 |
Why?
|
| Infant Formula | 1 | 2021 | 194 | 0.040 |
Why?
|
| Cough | 1 | 2023 | 594 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 2024 | 1085 | 0.040 |
Why?
|
| Consensus Development Conferences, NIH as Topic | 1 | 2019 | 29 | 0.040 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2021 | 289 | 0.040 |
Why?
|
| Blood Donors | 1 | 2021 | 345 | 0.040 |
Why?
|
| Zoonoses | 1 | 2020 | 179 | 0.040 |
Why?
|
| Housing | 1 | 2024 | 670 | 0.040 |
Why?
|
| Interferon-alpha | 1 | 2023 | 921 | 0.040 |
Why?
|
| National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2019 | 63 | 0.040 |
Why?
|
| Immunization, Passive | 1 | 2021 | 616 | 0.040 |
Why?
|
| RNA, Bacterial | 1 | 2021 | 393 | 0.040 |
Why?
|
| Rats, Inbred Strains | 2 | 1998 | 2088 | 0.040 |
Why?
|
| Receptors, Prostaglandin | 1 | 2018 | 53 | 0.040 |
Why?
|
| Immunization, Secondary | 1 | 2021 | 367 | 0.040 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2021 | 755 | 0.040 |
Why?
|
| Troponin | 1 | 2022 | 502 | 0.040 |
Why?
|
| Paris | 1 | 2018 | 41 | 0.040 |
Why?
|
| Chromatography, Gel | 2 | 2017 | 645 | 0.040 |
Why?
|
| Genome, Viral | 1 | 2022 | 667 | 0.040 |
Why?
|
| Losartan | 1 | 2000 | 265 | 0.040 |
Why?
|
| Liver | 1 | 2014 | 7529 | 0.040 |
Why?
|
| Ebolavirus | 1 | 2021 | 251 | 0.040 |
Why?
|
| Connective Tissue Diseases | 1 | 2021 | 285 | 0.040 |
Why?
|
| Pedigree | 2 | 2017 | 4542 | 0.040 |
Why?
|
| Proteins | 1 | 2013 | 6032 | 0.040 |
Why?
|
| DNA, Bacterial | 1 | 2023 | 1479 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 2 | 2017 | 6216 | 0.040 |
Why?
|
| Lymphopenia | 1 | 2020 | 281 | 0.040 |
Why?
|
| Interleukin-2 | 2 | 2022 | 1889 | 0.040 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2021 | 545 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2022 | 1699 | 0.040 |
Why?
|
| Immunity, Humoral | 1 | 2022 | 606 | 0.040 |
Why?
|
| Hematologic Neoplasms | 1 | 2009 | 1896 | 0.040 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2012 | 2422 | 0.040 |
Why?
|
| DNA, Protozoan | 3 | 1994 | 228 | 0.040 |
Why?
|
| Host-Parasite Interactions | 1 | 2020 | 300 | 0.040 |
Why?
|
| Cell Proliferation | 4 | 2017 | 10445 | 0.040 |
Why?
|
| Interferons | 1 | 2021 | 706 | 0.040 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2018 | 411 | 0.040 |
Why?
|
| Proteinuria | 5 | 1997 | 607 | 0.040 |
Why?
|
| Mucins | 2 | 1997 | 568 | 0.040 |
Why?
|
| Algorithms | 1 | 2018 | 14031 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2021 | 3745 | 0.040 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2017 | 364 | 0.040 |
Why?
|
| Immunohistochemistry | 4 | 2014 | 11076 | 0.040 |
Why?
|
| T-Cell Antigen Receptor Specificity | 1 | 2017 | 85 | 0.040 |
Why?
|
| Interleukin-6 | 4 | 2020 | 3208 | 0.040 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2020 | 411 | 0.040 |
Why?
|
| Risk | 2 | 2021 | 9610 | 0.040 |
Why?
|
| Neuroimmunomodulation | 1 | 2019 | 182 | 0.040 |
Why?
|
| Hemophilia A | 1 | 2000 | 360 | 0.040 |
Why?
|
| Pregnant Women | 1 | 2022 | 566 | 0.040 |
Why?
|
| Chemical Precipitation | 1 | 2017 | 175 | 0.040 |
Why?
|
| Caseins | 1 | 2017 | 104 | 0.030 |
Why?
|
| Microfluidics | 1 | 2022 | 653 | 0.030 |
Why?
|
| Creatinine | 1 | 2022 | 1899 | 0.030 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2017 | 161 | 0.030 |
Why?
|
| Circular Dichroism | 1 | 2017 | 344 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2020 | 629 | 0.030 |
Why?
|
| Patient Dropouts | 1 | 2019 | 412 | 0.030 |
Why?
|
| Mice, Inbred C3H | 1 | 2017 | 915 | 0.030 |
Why?
|
| Organ Preservation Solutions | 1 | 1997 | 100 | 0.030 |
Why?
|
| Drug Design | 2 | 1992 | 1048 | 0.030 |
Why?
|
| Glutens | 1 | 2018 | 240 | 0.030 |
Why?
|
| Ciprofloxacin | 1 | 1998 | 312 | 0.030 |
Why?
|
| Blood Proteins | 1 | 2021 | 1173 | 0.030 |
Why?
|
| Endoscopy, Digestive System | 1 | 2018 | 351 | 0.030 |
Why?
|
| Foster Home Care | 1 | 1997 | 133 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 2019 | 1991 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2024 | 1615 | 0.030 |
Why?
|
| Edetic Acid | 1 | 2016 | 280 | 0.030 |
Why?
|
| Nephrons | 1 | 1997 | 168 | 0.030 |
Why?
|
| Group Processes | 1 | 2017 | 228 | 0.030 |
Why?
|
| Chromatography, Ion Exchange | 2 | 1992 | 297 | 0.030 |
Why?
|
| Polysaccharides | 1 | 2022 | 1014 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 2015 | 5821 | 0.030 |
Why?
|
| Histamine | 1 | 2017 | 499 | 0.030 |
Why?
|
| Sulfhydryl Compounds | 1 | 2017 | 301 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 14666 | 0.030 |
Why?
|
| Autoimmunity | 2 | 2015 | 1356 | 0.030 |
Why?
|
| Interleukin-3 | 1 | 2016 | 425 | 0.030 |
Why?
|
| Cholesterol, HDL | 1 | 2021 | 1814 | 0.030 |
Why?
|
| Limit of Detection | 1 | 2016 | 273 | 0.030 |
Why?
|
| Prisons | 1 | 1997 | 174 | 0.030 |
Why?
|
| Receptors, Cytokine | 1 | 1996 | 258 | 0.030 |
Why?
|
| Brain Death | 1 | 1998 | 357 | 0.030 |
Why?
|
| Myosin Type II | 1 | 2014 | 70 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 1997 | 553 | 0.030 |
Why?
|
| Minority Groups | 1 | 2022 | 1203 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2000 | 1440 | 0.030 |
Why?
|
| Furans | 1 | 1995 | 202 | 0.030 |
Why?
|
| Forced Expiratory Flow Rates | 1 | 2014 | 75 | 0.030 |
Why?
|
| Leukocytes | 1 | 2022 | 2026 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2015 | 413 | 0.030 |
Why?
|
| Electric Impedance | 1 | 2018 | 757 | 0.030 |
Why?
|
| HSC70 Heat-Shock Proteins | 1 | 1994 | 49 | 0.030 |
Why?
|
| Nicotine | 1 | 2019 | 680 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2020 | 1493 | 0.030 |
Why?
|
| Triage | 1 | 2021 | 986 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2018 | 918 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2017 | 416 | 0.030 |
Why?
|
| Mutation, Missense | 2 | 2014 | 2571 | 0.030 |
Why?
|
| Triglycerides | 1 | 2021 | 2461 | 0.030 |
Why?
|
| Cross-Linking Reagents | 1 | 2017 | 687 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2020 | 1188 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 2015 | 1060 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 3810 | 0.030 |
Why?
|
| Organ Preservation | 1 | 1997 | 382 | 0.030 |
Why?
|
| Outpatients | 1 | 2021 | 1597 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 2016 | 1157 | 0.030 |
Why?
|
| Disease Outbreaks | 1 | 2023 | 1749 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2011 | 5671 | 0.030 |
Why?
|
| Sex Factors | 2 | 2019 | 10552 | 0.030 |
Why?
|
| Cyclosporins | 1 | 1993 | 216 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2015 | 1762 | 0.030 |
Why?
|
| Temperature | 2 | 2016 | 2226 | 0.030 |
Why?
|
| Magnetics | 1 | 2016 | 599 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2021 | 2330 | 0.030 |
Why?
|
| DNA Mutational Analysis | 2 | 2011 | 4111 | 0.030 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 1993 | 97 | 0.030 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2015 | 384 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1994 | 1141 | 0.030 |
Why?
|
| Point-of-Care Systems | 1 | 2021 | 1213 | 0.030 |
Why?
|
| Crithidia | 1 | 1992 | 2 | 0.030 |
Why?
|
| Immunization | 1 | 2017 | 1228 | 0.030 |
Why?
|
| Th1-Th2 Balance | 1 | 2012 | 38 | 0.030 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2012 | 144 | 0.030 |
Why?
|
| Glutathione Reductase | 1 | 1992 | 25 | 0.030 |
Why?
|
| Genotype | 3 | 2011 | 12990 | 0.020 |
Why?
|
| Anemia, Aplastic | 1 | 2014 | 230 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2021 | 2382 | 0.020 |
Why?
|
| Ischemia | 2 | 1997 | 1882 | 0.020 |
Why?
|
| Trypanosomiasis, African | 1 | 1992 | 30 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2016 | 1755 | 0.020 |
Why?
|
| India | 1 | 2018 | 2348 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2021 | 2049 | 0.020 |
Why?
|
| Blood Cell Count | 1 | 2012 | 397 | 0.020 |
Why?
|
| Leishmania tropica | 1 | 1991 | 8 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2013 | 550 | 0.020 |
Why?
|
| Incidence | 2 | 2024 | 21353 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 1992 | 1693 | 0.020 |
Why?
|
| Phlebotomus | 1 | 1991 | 12 | 0.020 |
Why?
|
| Child Health Services | 1 | 1997 | 646 | 0.020 |
Why?
|
| Cell Line | 3 | 2016 | 15601 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 2141 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2012 | 2469 | 0.020 |
Why?
|
| Respiratory Sounds | 1 | 2015 | 702 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2020 | 4278 | 0.020 |
Why?
|
| Protein Binding | 2 | 1994 | 9351 | 0.020 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2012 | 168 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2020 | 14414 | 0.020 |
Why?
|
| Boston | 1 | 2024 | 9326 | 0.020 |
Why?
|
| Drug Resistance | 2 | 2014 | 1596 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 2012 | 523 | 0.020 |
Why?
|
| Protein Transport | 1 | 2017 | 1967 | 0.020 |
Why?
|
| Ligases | 1 | 1992 | 333 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 2020 | 0.020 |
Why?
|
| beta-Glucans | 1 | 2011 | 123 | 0.020 |
Why?
|
| Body Mass Index | 2 | 2021 | 12953 | 0.020 |
Why?
|
| Ear, Inner | 1 | 2014 | 425 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 1998 | 983 | 0.020 |
Why?
|
| Caregivers | 1 | 2023 | 2237 | 0.020 |
Why?
|
| Alleles | 1 | 2022 | 6863 | 0.020 |
Why?
|
| Rural Population | 1 | 2021 | 2285 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 1459 | 0.020 |
Why?
|
| Consensus | 1 | 2020 | 3123 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1992 | 779 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2018 | 1902 | 0.020 |
Why?
|
| Fruit | 1 | 2015 | 1160 | 0.020 |
Why?
|
| Vegetables | 1 | 2015 | 1195 | 0.020 |
Why?
|
| Critical Illness | 1 | 2023 | 2723 | 0.020 |
Why?
|
| Chagas Disease | 1 | 1992 | 167 | 0.020 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2022 | 2151 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2012 | 603 | 0.020 |
Why?
|
| Lymphocyte Count | 1 | 2012 | 778 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2017 | 1779 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2021 | 3312 | 0.020 |
Why?
|
| Genes, Viral | 1 | 1991 | 649 | 0.020 |
Why?
|
| Recombinant Proteins | 3 | 1998 | 6534 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2021 | 2521 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2021 | 3466 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2013 | 727 | 0.020 |
Why?
|
| Virus Diseases | 1 | 2015 | 718 | 0.020 |
Why?
|
| Proton Pump Inhibitors | 1 | 2014 | 532 | 0.020 |
Why?
|
| Disease Management | 1 | 2020 | 2508 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2017 | 2416 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2021 | 15936 | 0.020 |
Why?
|
| Glucose | 1 | 2021 | 4346 | 0.020 |
Why?
|
| Heparin | 1 | 2016 | 1634 | 0.020 |
Why?
|
| Oxidation-Reduction | 2 | 1992 | 2231 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 10766 | 0.020 |
Why?
|
| Lymphoma, B-Cell | 1 | 2015 | 940 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 3 | 1997 | 1435 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2011 | 903 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 1994 | 3076 | 0.020 |
Why?
|
| Thymus Gland | 1 | 2013 | 1243 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2016 | 3968 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1992 | 2748 | 0.020 |
Why?
|
| Asymptomatic Diseases | 1 | 2011 | 588 | 0.020 |
Why?
|
| Protein Engineering | 1 | 1992 | 549 | 0.020 |
Why?
|
| Heterozygote | 1 | 2014 | 2787 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2017 | 2909 | 0.020 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2011 | 891 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2012 | 1638 | 0.020 |
Why?
|
| Equipment Design | 1 | 2016 | 3510 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 1992 | 1791 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2021 | 3963 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2015 | 4853 | 0.020 |
Why?
|
| Endothelins | 2 | 1997 | 127 | 0.020 |
Why?
|
| Health Behavior | 1 | 2019 | 2643 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2019 | 1860 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2014 | 2707 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2011 | 1341 | 0.020 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2009 | 289 | 0.020 |
Why?
|
| Health Personnel | 1 | 2021 | 3335 | 0.020 |
Why?
|
| Simplexvirus | 1 | 1991 | 803 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2017 | 1809 | 0.020 |
Why?
|
| Hypertension | 2 | 2020 | 8540 | 0.020 |
Why?
|
| Gene Library | 1 | 2009 | 1059 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 1991 | 1519 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2022 | 3763 | 0.020 |
Why?
|
| Kidney Glomerulus | 2 | 2000 | 568 | 0.020 |
Why?
|
| Acute Kidney Injury | 1 | 1998 | 1924 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2014 | 1600 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2010 | 1416 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 3 | 1997 | 1961 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2011 | 1971 | 0.020 |
Why?
|
| Prednisone | 1 | 2010 | 1563 | 0.020 |
Why?
|
| DNA Primers | 1 | 2009 | 2819 | 0.020 |
Why?
|
| Antibodies | 1 | 2013 | 2418 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3778 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2017 | 9646 | 0.010 |
Why?
|
| Drosophila | 1 | 1992 | 1495 | 0.010 |
Why?
|
| Neoplasm, Residual | 1 | 2009 | 1008 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1995 | 8181 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 9539 | 0.010 |
Why?
|
| Linear Models | 1 | 2014 | 5871 | 0.010 |
Why?
|
| ROC Curve | 1 | 2012 | 3579 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1991 | 1363 | 0.010 |
Why?
|
| Anxiety | 1 | 2019 | 4573 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2023 | 7879 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 2011 | 1181 | 0.010 |
Why?
|
| Registries | 1 | 2019 | 8224 | 0.010 |
Why?
|
| Research Design | 1 | 2019 | 6180 | 0.010 |
Why?
|
| Liver Transplantation | 1 | 2014 | 2330 | 0.010 |
Why?
|
| Nephrectomy | 2 | 1997 | 937 | 0.010 |
Why?
|
| Blotting, Southern | 2 | 1994 | 777 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2011 | 4141 | 0.010 |
Why?
|
| Logistic Models | 1 | 2015 | 13255 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2016 | 4812 | 0.010 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2000 | 60 | 0.010 |
Why?
|
| Ligands | 2 | 1997 | 3272 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1992 | 5112 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2010 | 4243 | 0.010 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2000 | 153 | 0.010 |
Why?
|
| Trazodone | 1 | 1998 | 68 | 0.010 |
Why?
|
| Hemodynamics | 2 | 2000 | 4159 | 0.010 |
Why?
|
| Complement C1 | 1 | 1997 | 32 | 0.010 |
Why?
|
| Raffinose | 1 | 1997 | 53 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2010 | 5972 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2012 | 6567 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2012 | 7967 | 0.010 |
Why?
|
| Endothelin-1 | 1 | 1997 | 302 | 0.010 |
Why?
|
| Allopurinol | 1 | 1997 | 198 | 0.010 |
Why?
|
| Complement C3 | 1 | 1997 | 435 | 0.010 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 1998 | 489 | 0.010 |
Why?
|
| E-Selectin | 1 | 1997 | 576 | 0.010 |
Why?
|
| Isoantigens | 1 | 1996 | 551 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1998 | 1880 | 0.010 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 1997 | 335 | 0.010 |
Why?
|
| Cold Temperature | 1 | 1997 | 785 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2009 | 8547 | 0.010 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2000 | 1039 | 0.010 |
Why?
|
| Interleukins | 1 | 1997 | 782 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1998 | 4174 | 0.010 |
Why?
|
| Cryopreservation | 1 | 1997 | 728 | 0.010 |
Why?
|
| Deuterium | 1 | 1992 | 106 | 0.010 |
Why?
|
| Organ Size | 1 | 1997 | 2254 | 0.010 |
Why?
|
| Tritium | 1 | 1992 | 708 | 0.010 |
Why?
|
| Adenosine | 1 | 1997 | 808 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 1994 | 565 | 0.010 |
Why?
|
| NADP | 1 | 1992 | 227 | 0.010 |
Why?
|
| Solvents | 1 | 1992 | 295 | 0.010 |
Why?
|
| Bucladesine | 1 | 1991 | 118 | 0.010 |
Why?
|
| TATA Box | 1 | 1991 | 127 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1991 | 851 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 1997 | 2206 | 0.010 |
Why?
|
| Vero Cells | 1 | 1991 | 482 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1991 | 817 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1991 | 1302 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1992 | 1541 | 0.000 |
Why?
|
| Glomerular Filtration Rate | 1 | 1997 | 2176 | 0.000 |
Why?
|
| Oligopeptides | 1 | 1994 | 1187 | 0.000 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 1991 | 502 | 0.000 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 12148 | 0.000 |
Why?
|
| Nerve Growth Factors | 1 | 1991 | 564 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1992 | 2496 | 0.000 |
Why?
|
| Acute Disease | 1 | 1998 | 7237 | 0.000 |
Why?
|
| Species Specificity | 1 | 1991 | 2414 | 0.000 |
Why?
|
| Body Weight | 1 | 1997 | 4618 | 0.000 |
Why?
|
| Gene Amplification | 1 | 1991 | 1089 | 0.000 |
Why?
|
| Kidney Diseases | 1 | 1997 | 2091 | 0.000 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1994 | 3734 | 0.000 |
Why?
|
| Bacterial Proteins | 1 | 1998 | 3847 | 0.000 |
Why?
|
| Genetic Markers | 1 | 1991 | 2601 | 0.000 |
Why?
|
| Insulin | 1 | 1997 | 6596 | 0.000 |
Why?
|